Last quarter (Q4 2023), Molecular Templates's total revenue was $―, a decrease of ― from the same quarter last year. In Q4, Molecular Templates's net income was $-6.23M. See Molecular Templates’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	-	-	-	-	$ 15.63M	$ 22.27M
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
Operating Expense	$ 67.77M	$ 67.77M	$ 108.63M	$ 122.14M	$ 116.48M	$ 70.60M
Operating Income	$ -55.35M	$ -10.47M	$ -88.87M	$ -122.14M	$ -100.84M	$ -48.33M
Net Non Operating Interest Income Expense	$ 1.21M	$ 1.21M	$ 988.00K	$ 434.00K	$ -677.00K	$ 1.02M
Other Income Expense	$ -58.63M	$ -58.63M	$ -19.75M	$ -38.70M	$ -3.39M	$ -22.12M
Pretax Income	$ -8.13M	$ -8.13M	$ -92.67M	$ -83.01M	$ -104.91M	$ -69.42M
Tax Provision	$ -11.00K	$ -11.00K	$ 53.00K	-	$ 5.00K	$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -9.52M	$ -8.12M	$ -92.72M	$ -83.01M	$ -104.92M	$ -69.42M
Basic EPS	$ 1.80	$ 1.80	$ 1.65	$ 1.50	$ -2.20	$ -1.86
Diluted EPS	$ 1.80	$ 1.80	$ 1.65	$ 1.50	$ -2.20	$ -1.86
Basic Average Shares	$ 123.19M	$ 4.50M	$ 56.33M	$ 55.30M	$ 47.60M	$ 37.77M
Diluted Average Shares	$ 123.19M	$ 4.50M	$ 56.33M	$ 55.30M	$ 47.60M	$ 37.77M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 67.77M	$ 67.77M	$ 108.63M	$ 122.14M	$ 116.48M	$ 70.60M
Net Income From Continuing And Discontinued Operation	$ -9.52M	$ -8.12M	$ -92.72M	$ -83.01M	$ -104.92M	$ -69.42M
Normalized Income	$ -15.39M	$ -7.39M	-	-	$ -102.44M	$ -47.30M
Interest Expense	-	-	-	-	$ 1.71M	$ 1.30M
EBIT	$ -8.13M	$ -8.13M	$ -92.67M	$ -83.01M	$ -103.21M	$ -68.12M
EBITDA	$ -1.10M	$ -1.10M	$ -84.31M	$ -75.64M	$ -99.29M	$ -66.94M

Currency in USD

Molecular Templates Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing